For (ex)entrepreneurs, families, wealthy individuals, business professionals, healthcare professionals and executives.
For family offices, foundations & charities and independent asset managers.
For institutional and wholesale clients.
For corporates, institutional investors and private equity.
Van Lanschot Kempen closely monitors markets and economic developments. Stay informed and up to date on current topics. Read our articles, watch our videos and listen to our podcasts.
Read more about our organisation, news, investor relations and our contribution to a sustainable society.
Read more about working at Van Lanschot Kempen and view current vacancies.
Read more about Evi, our online investment coach.
Read more about our expertise and offices in different countries.
Are you already a client or interested in our services? We are happy to help you.
We are happy to speak to you in person. Call us or click on the link below for more contact options and locations.
The Netherlands
+31 (0800) 17 37Belgium
(+32) 3 286 69 80Switzerland
(+41) 43 377 11 11We are happy to speak to you in person. Call us or click on the link below for more contact options and locations.
The Netherlands
+31 (020) 348 80 00United Kingdom
+44 20 3636 9400United States of America
+1 212 376 0134Co-Lead Manager
Kempen & Co acted as Co-Lead Manager in Zealand Pharma’s DKK 786m Capital Increase
Zealand Pharma (Nasdaq: ZEAL) is a biotechnology company focused on discovering, developing, and commercialising peptide-based medicines. More than ten drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market, and three candidates are in late-stage development.
In March 2022, Zealand Pharma announced a new strategy to pursue strategic partners for the commercialisation and co-development of late-stage clinical assets and prioritize resources on R&D.
The company has development partnerships with a number of blue-chip pharma companies as well as commercial partnerships for its marketed products.
Founded in 1998 and headquartered in Copenhagen, Denmark, Zealand Pharma has a team in the U.S.
In the last twelve months, Kempen & Co has successfully completed a large number of equity capital markets transactions in its Life Sciences & Healthcare franchise. Recent transactions include: